Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect
Clinical trial NCT01344967 · COMPLETED
Trial details
- NCT number
- NCT01344967
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.